ALEKSANDAR ROSICH: Open Payments
NPI 1972606028 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 16 payments from 7 companies in 2025. Trend: 2023 $839 · 2024 $786 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $375 |
| AstraZeneca Pharmaceuticals LP | 2 | $210 |
| Teva Pharmaceuticals USA, Inc. | 4 | $200 |
| Aimmune Therapeutics, Inc. | 3 | $113 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Boston Scientific Corporation | 1 | $35 |
| Lundbeck LLC | 1 | $26 |
Products named: ULTOMIRIS, LOKELMA, AUSTEDO XR, ZENPEP, INGREZZA, VOWST, WATCHMAN Access System, REXULTI.
Industry payments across WI — which companies pay providers there.
